We are live on ! Find out more
NR

Newfound Research Portfolio holdings

AUM $40.8M
1-Year Est. Return 12.42%
This Fund
S&P 500
This Quarter Est. Return
+11.46%
1 Year Est. Return
-12.42%
3 Year Est. Return
+54.59%
5 Year Est. Return
+89.01%
10 Year Est. Return
AUM
$38.9M
AUM Growth
+$3.87M
Cap. Flow
+$1.51M
Cap. Flow %
3.88%
Top 10 Hldgs %
70.48%
Holding
171
New
61
Increased
64
Reduced
1
Closed
45
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALXN
76
DELISTED
Alexion Pharmaceuticals
ALXN
$106K 0.27%
+680
New +$87.4K
LIN icon
77
Linde
LIN
$224B
$103K 0.27%
+391
New +$96K
CSGP icon
78
CoStar Group
CSGP
$12.7B
$102K 0.26%
1,100
+670
+156% +$58.7K
CTAS icon
79
Cintas
CTAS
$81.7B
$102K 0.26%
+1,156
New +$100K
IEP icon
80
Icahn Enterprises
IEP
$4.78B
$99K 0.25%
+1,953
New +$99.4K
META icon
81
Meta Platforms (Facebook)
META
$1.45T
$98K 0.25%
360
+207
+135% +$56.7K
JKHY icon
82
Jack Henry & Associates
JKHY
$12.1B
$95K 0.24%
586
+437
+293% +$69.4K
FDS icon
83
Factset
FDS
$10.8B
$94K 0.24%
+284
New +$93.9K
SPGI icon
84
S&P Global
SPGI
$128B
$90K 0.23%
+273
New +$92.1K
MDT icon
85
Medtronic
MDT
$115B
$89K 0.23%
+758
New +$83.4K
TYL icon
86
Tyler Technologies
TYL
$15.1B
$89K 0.23%
205
+130
+173% +$53.6K
AME icon
87
Ametek
AME
$55.9B
$88K 0.23%
+728
New +$82K
EA
88
DELISTED
Electronic Arts
EA
$85K 0.22%
593
+354
+148% +$45.6K
RMD icon
89
ResMed
RMD
$34B
$85K 0.22%
398
+229
+136% +$45.7K
GWW icon
90
W.W. Grainger
GWW
$62.2B
$84K 0.22%
+205
New +$80.6K
DHR icon
91
Danaher
DHR
$152B
$82K 0.21%
418
+223
+114% +$44.7K
TMO icon
92
Thermo Fisher Scientific
TMO
$233B
$82K 0.21%
175
+93
+113% +$43.6K
BMY icon
93
Bristol-Myers Squibb
BMY
$137B
$79K 0.2%
+1,281
New +$78.8K
MDLZ icon
94
Mondelez International
MDLZ
$79.7B
$79K 0.2%
+1,347
New +$77K
DG icon
95
Dollar General
DG
$27.8B
$78K 0.2%
372
+229
+160% +$48.9K
CABO icon
96
Cable One
CABO
$128M
$71K 0.18%
+32
New +$63.3K
PODD icon
97
Insulet
PODD
$9.95B
$65K 0.17%
254
+120
+90% +$29.8K
ROL icon
98
Rollins
ROL
$17.3B
$64K 0.16%
1,642
+685
+72% +$26.5K
EFX icon
99
Equifax
EFX
$22.4B
$62K 0.16%
+322
New +$54.1K
TIF
100
DELISTED
Tiffany & Co.
TIF
$61K 0.16%
466
+281
+152% +$36K

Similar funds

Newfound Research's Q4 2020 Portfolio in Review

As of Q4 2020, Newfound Research held 171 positions worth $38.9M, up 11% from $35M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Newfound Research deployed $1.51M of net new capital in Q4 2020, opening 61 new positions and adding to 64 existing holdings. Its largest new stake was JPMorgan US Momentum Factor ETF: 97,159 shares worth $3.78M.

By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, down from 92% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Cadence Design Systems, an estimated $2.93K trimmed.

  • Newfound Research's largest Q4 2020 buy was JPMorgan US Momentum Factor ETF: 97,159 shares worth $3.78M.
  • Newfound Research added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $9.08M increase.
  • Newfound Research's biggest Q4 2020 reduction was Cadence Design Systems, cutting an estimated $2.93K.
  • Newfound Research fully exited State Street Health Care Select Sector SPDR ETF in Q4 2020, selling an estimated $2.1M.
  • Newfound Research's ten largest holdings make up 70% of its $38.9M portfolio in Q4 2020.
  • Newfound Research opened 61 new positions and closed 45 in Q4 2020.
  • Newfound Research's portfolio value rose 11% quarter-over-quarter to $38.9M.

Based on Newfound Research's 13F filing for Q4 2020, filed 22 Jan 2021.